Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Buy
55
HQY Quote, Financials, Valuation and Earnings
Last price:
$97.57
Seasonality move
:
8.23%
Day range:
$96.72 - $98.50
52-week range:
$65.01 - $105.82
Dividend yield:
0%
P/E ratio:
89.42x
P/S ratio:
7.48x
P/B ratio:
3.98x
Volume:
431.3K
Avg. volume:
767.6K
1-year change:
43.97%
Market cap:
$8.4B
Revenue:
$999.6M
EPS (TTM):
$1.09
Analysts' Opinion
-
Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $113.00, HealthEquity has an estimated upside of 15.93% from its current price of $97.47.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $102.00 representing 100% downside risk from its current price of $97.47.
Fair Value
-
According to the consensus of 9 analysts, HealthEquity has 15.93% upside to fair value with a price target of $113.00 per share.
HQY vs. S&P 500
-
Over the past 5 trading days, HealthEquity has overperformed the S&P 500 by 0.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
HealthEquity does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HealthEquity has grown year-over-year revenues for 14 quarters straight. In the most recent quarter HealthEquity reported revenues of $300.4M.
Earnings Growth
-
HealthEquity earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter HealthEquity reported earnings per share of $0.06.
Enterprise value:
9.2B
EV / Invested capital:
--
Price / LTM sales:
7.48x
EV / EBIT:
52.66x
EV / Revenue:
8.00x
PEG ratio (5yr expected):
0.40x
EV / Free cash flow:
-56.83x
Price / Operating cash flow:
35.43x
Enterprise value / EBITDA:
27.40x
Gross Profit (TTM):
$751.5M
Return On Assets:
2.93%
Net Income Margin (TTM):
8.41%
Return On Equity:
4.65%
Return On Invested Capital:
3.17%
Operating Margin:
18%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $831.2M | $971M | $1.2B | $249.2M | $300.4M | |
| Gross Profit | $462.2M | $595.4M | $751.5M | $159.2M | $197M | |
| Operating Income | $18.5M | $105.3M | $199.7M | $33.5M | $54.1M | |
| EBITDA | $122.5M | $257.1M | $336M | $72.4M | $65.1M | |
| Diluted EPS | -$0.70 | $0.34 | $1.09 | $0.17 | $0.06 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $396M | $764.1M | $332.2M | $474.4M | $495.2M | |
| Total Assets | $2.7B | $3.1B | $3.1B | $3.1B | $3.5B | |
| Current Liabilities | $151.4M | $107.1M | $110.4M | $96.2M | $154.5M | |
| Total Liabilities | $1.3B | $1.2B | $1.2B | $1.1B | $1.4B | |
| Total Equity | $1.4B | $1.9B | $1.9B | $2B | $2.1B | |
| Total Debt | $1B | $930.1M | $926.7M | $874.3M | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $145.7M | $221.2M | $341.2M | $57.1M | $90.6M | |
| Cash From Investing | -$580.2M | -$45.1M | -$503.2M | -$15.4M | -$12.9M | |
| Cash From Financing | -$4.5M | -$52.3M | $150.1M | $2M | -$82.4M | |
| Free Cash Flow | $20.6M | $176.2M | -$162M | $41.7M | $77.7M | |
HQY
Sector
Market Cap
$8.4B
$49.2M
Price % of 52-Week High
92.11%
48.57%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
43.97%
-30.94%
Beta (5-Year)
0.543
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$96.44
200-day SMA
Buy
Level
$83.73
Bollinger Bands (100)
Buy
Level
77.58 - 97.58
Chaikin Money Flow
Buy
Level
76.2M
20-day SMA
Buy
Level
$96.12
Relative Strength Index (RSI14)
Buy
Level
53.26
ADX Line
Buy
Level
37.25
Williams %R
Sell
Level
-12.6225
50-day SMA
Buy
Level
$96.26
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
109.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1702)
Buy
CA Score
(Annual)
Level (0.4387)
Buy
Beneish M-Score
(Annual)
Level (-2.7162)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-2.02)
Buy
Piotroski F Score
(Annual)
Level (9)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Stock Forecast FAQ
In the current month, HQY has received 8 Buy ratings 1 Hold ratings, and 0 Sell ratings. The HQY average analyst price target in the past 3 months is $113.00.
-
Where Will HealthEquity Stock Be In 1 Year?
According to analysts, the consensus estimate is that HealthEquity share price will rise to $113.00 per share over the next 12 months.
-
What Do Analysts Say About HealthEquity?
Analysts are divided on their view about HealthEquity share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthEquity is a Sell and believe this share price will drop from its current level to $102.00.
-
What Is HealthEquity's Price Target?
The price target for HealthEquity over the next 1-year time period is forecast to be $113.00 according to 9 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is HQY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HealthEquity is a Buy. 8 of 9 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HQY?
You can purchase shares of HealthEquity via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthEquity shares.
-
What Is The HealthEquity Share Price Today?
HealthEquity was last trading at $97.57 per share. This represents the most recent stock quote for HealthEquity. Yesterday, HealthEquity closed at $97.47 per share.
-
How To Buy HealthEquity Stock Online?
In order to purchase HealthEquity stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
